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1. Introduction 
In theory, the kinds and relative amounts of aconitum alkaloids in 
proprietary Chinese medicines should be consistent with those in Fuzi. However, this 
feature has not been noted enough and no direct experimental evidence to prove it. In this 
work MALDI-TOF-MS was used to analysis 19 kinds of proprietary Chinese medicines, 
benzoylmesaconine and hypaconitine have been proved to be the predominant monoester 
and diester alkaloids respectively. In addition, the MALDI-TOF analysis of the concoction of 
seven kinds of Chinese medicine has confirmed that the acidity of concoction will improve 
the aconitines contents and the toxicity of concoction, but this rule was not suited for 
Lonicera nitida, Rhizoma Chuanxiong or Chaenomeles sinensis. 
The Aconitum plants are widely used in China as an analgesic, a cardiotonic, and an anti 
rheumatism treatment. Among all the species Aconitum, the lateral roots of Aconite 
(Aconitum Camicheali Debx, Fuzi), main roots of Aconite (Chuanwu) and roots of 
Aconitum kusnezoffii Reichb (Caowu) are the three kinds of plant medicines that are 
collected in Chinese Pharmacopoeia, and some of other Aconitum plants have been used as 
folk medicine. It is well known that diester diterpenoid aconitine (DDA) and its analogues 
isolated from Aconitum plants contribute to the bioactivity and the high toxicity for the 
heart and the central nervous system. Fortunately, aconitines are heat-unstable and will be 
conversed into less toxic monoester diterpenoid alkaloids (MDA) or lipo-alkaloids after 
processing [1], therefore, the amounts of highly toxic aconitine are lower than those of 
monoester diterpenoid alkaloids in processed aconite and proprietary Chinese medicines 
(PCMs). 
For monitoring the possible toxicity of Chinese medicines, high-performance liquid 
chromatography (HPLC) has been frequently used for quantification analysis of aconitines. 
Generally, only aconitine, mesaconitine and hypaconitine three standards could be 
purchased and most of research was limited in these 3 alkaloids [2]. Therefore, qualitative 
analysis is also essential for PCM besides quantitative analysis. In contrast to 
chromatographic methods, matrix-assisted laser desorption time-of-flight mass 
spectrometry (MALDI-TOF-MS) determines the molecular mass of alkaloids, which 
represents an inherent physical property and is feasible for high-throughput analysis of 
different samples containing aconitines.  
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In this work, we have analyzed aconitum alkaloids in 19 kinds PCMs and found that 
hypaconitine is the dominant DDA in the 12 oral PCMs, which is somewhat different from 
previous quantitative results of aconitines in PCM reported by using HPLC method [3]. 
These PCMs include Guifudihuangwan (GFDHW), Fuzilizhongwan (FZLZW), 
Jinkuishenqiwan(JKSQW), Xiaohuoluowan (XHLW), Sanhanhuoluowan (SHHLW), 
Zuifengtouguwan (ZFTGW), Narusanwewan (NRSWW), Muguawan (MGW), Xiaojinwan 
(XJW), Haimabushenwan (HMBSW, Dahuoluowan (DHLW), Panlongqipian (PLQP), 
Fufangxuelianjiaonang (FFXLJN), Diedazhentonggao (DDZTG), Tiebangcuizhitonggao 
(TBCZTG), Guzengshengzhentonggao (GZSZTG), Shexiangzuifenggao (SXZFG), 
Zhentonglingding (ZTLD) and Shangtongding (STD).  
On the other hand, the detoxification mechanism of aconite in concoction is far away from 
clear. For example, acidity is one of the factors to influence the hydrolysis of aconitines [4]. 
Here we have concocted Fuzi with 7 others herbal Medicines and analyzed the alkaloids in 
the concoction by MALDI-TOF-MS. We have found that acidity is not the only factor that 
affects the hydrolysis reaction of DDAs as well as the amounts of aconitines because of the 
complexity of Chinese medicine. 
1.1 Experimental 
Prepared root of aconite and all proprietary Chinese medicine (PCM) were purchased from 
drug store; 5g dried and powered aconite root or PCM were soaked with 60 mL ethanol for 
48 h at room temperature, and the resulting solution of alkaloids was diluted with 50% 
ethanol for further analysis of MALDI-TOF.  
1.2 Mass spectrometry 
All experiments were performed using a Voyager DE-STR MALDI-TOF mass spectrometer 
(Applied Biosystems) The Voyager DE STR was operated in a positive reflector mode with 
the following parameters: acquisition mass range, 400-1000 Da; accelerating voltage, 20,000 
V; grid voltage, 73%; mirror voltage ratio, 1.14; guide wire, 0.01%; low mass gate set at 300; 
extraction delay time, 150 ns; and the laser power attenuator set at 2700, total 100 
shots/spectrum. Matrix solution was prepared by dissolving 8mg of α-cyano-4-
hydroxycinnamic acid (CHCA) in 1 ml of 1:1 mixture of acetonitrile and 0.1% trifluoroacetic 
acid.  
2. Results and discussions 
2.1 The MALDI-TOF analysis of nineteen kinds of PCM 
For aconitum alkaloids, protonated molecules (M+H) + were observed by MALDI-MS in 
positive ion mode. The structures of aconitum alkaloids are very similar and it is reasonable 
to assume that they have similar ionization efficiencies [5]. The alkaloids of 13 oral 
administration pills or tablets that using prepared aconite roots have been analyzed firstly. 
As shown in Fig.1-Fig.13, benzoylhypaconine (BHA, m/z 574), benzoylmesaconine (BMA, 
m/z 590) and benzoylaconine (BAC, m/z 604) were the major components, hypaconitine 
(HA, m/z 616)  is the most main diester alkaloids, additionally, deoxyaconitine (DA, m/z 
630), mesaconitine (MA, mz/ 632) and aconitine (AC, m/z 646) can also be observed. In all 
13 PCMs, HMBSW exhibit the most high relative abundance of the highly toxic diester 
aconitines (Fig.12), however, different with some previous report that obtained by high 
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performance liquid chromatography [3], it is HA other than MA is the dominant aconitine, in 
addition, 10-OH-MA (m/z 648) and 10-OH-AC (m/z 662) have been detected also. We 
believe our result is reasonable because MA is more prone to be hydrolyzed to BMA after 
boiling [1] and HA is the main aconitine in prepared aconite roots [5]. An exception is 
Daguoluowan, only BMA was detected with a weak signal. According to the ancient 
Chinese concept of Yin-Yang, Aconite is one of the most important herbal medicines that 
related Yang deficiency and relieving pain, so a certain amount of monoester aconitum 
alkaloids and diester alkaloids is essential for the treatment. Generally, in the mass region of 
m/z 400-500, talatizidine, talatisamine, neoline, fuziline and 14-acetyl- talatisamine can be 
detected at m/z 408, m/z422, m/z 438, m/z 545 and m/z 464 respectively owing to they 
also exist in prepared Fuzi [6]. Secondly, for the vitro dosage form such as plaster or tincture, 
some obvious changes have been observed. Aconitine at m/z 646 has been detected as the 
main alkaloids in DDZTG (Fig.14), TBCZTG (Fig.15), GZSZTG (Fig.16), and STD (Fig.17); 
thirdly, mesaconitine is the most high content alkaloids in SXZFG (Fig.18); fourthly, high 
abundance of HA, DA, MA and AC have been detected in ZTLD.  
In sum, because of the high ionization efficiency of alkaloids, aconitines and their hydrolysis 
products can be easily analyzed by MALDI-TOF after extracted by chloroform, thus, 
MALDI-TOF mass spectrometry provides a rapid, sensitive, simple and specific method for 
the qualitative analysis of alkaloids mixtures in complex systems such as proprietary 
Chinese. By comparing the relative abundance of DDA and MDA, we can further acquire 
relatively quantitative information of aconitum alkaloids. Actually, as an analysis method 
that based on mass isolation, mass spectrometry method is especially suit for the well-
known research system such as aconitum alkaloids. 
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Fig. 1. MALDI-TOF spectrum of GFDHW 
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Fig. 2. MALDI-TOF spectrum of FZLZW 
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Fig. 3. MALDI-TOF spectrum of JKSQW 
 
399.0 519.4 639.8 760.2 880.6 1001.0
Mass (m/z)
2.5E+4
0
10
20
30
40
50
60
70
80
90
100
%
 I
n
te
n
s
it
y
Voyager Spec #1[BP = 590.3, 25262]
590.26
591.27
574.27
616.28
422.26
558.28
605.28464.27408.24 559.28 700.24632.29 877.01665.98525.23
 
Fig. 4. MALDI-TOF spectrum of XHLW 
 
399.0 519.4 639.8 760.2 880.6 1001.0
Mass (m/z)
2.5E+4
0
10
20
30
40
50
60
70
80
90
100
%
 I
n
te
n
s
it
y
Voyager Spec #1[BP = 590.3, 25162]
590.34
574.34
438.31
591.35
408.30
454.31 616.35
558.34
464.33
424.30 605.36556.33
409.30 465.33 606.34 700.33570.35 912.47530.35 646.37
 
Fig. 5. MALDI-TOF spectrum of SHLLW 
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Fig. 6. MALDI-TOF spectrum of ZFTGW 
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Fig. 7. MALDI-TOF spectrum of NRSWW 
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Fig. 8. MALDI-TOF spectrum of MGW 
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Fig. 9. MALDI-TOF spectrum of PLQP 
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Fig. 10. MALDI-TOF spectrum of XJW 
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Fig. 11. MALDI-TOF spectrum of FFXLJN 
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Fig. 12. MALDI-TOF spectrum of HMBSW 
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Fig. 13. MALDI-TOF spectrum of DHLW 
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Fig. 14. MALDI-TOF spectrum of DDZTG 
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Fig. 15. MALDI-TOF spectrum of TBCZTG 
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Fig. 16. MALDI-TOF spectrum of GZSZTG 
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Fig. 17. MALDI-TOF spectrum of STD 
www.intechopen.com
 
Recent Advances in Theories and Practice of Chinese Medicine 
 
378 
534 589 644 699 754 809
Mass (m/z)
4731.0
0
10
20
30
40
50
60
70
80
90
100
%
 I
n
te
n
s
it
y
Voyager Spec #1[BP = 589.2, 4731]
589.24
683.33
590.25
684.34
632.35 669.32
604.32
670.32
633.35605.32 653.34 768.48716.29
686.34 732.27 749.31556.30 586.30 623.26
 
Fig. 18. MALDI-TOF spectrum of SXZFG 
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Fig. 19. MALDI-TOF spectrum of ZTLD 
2.2 The MALDI-TOF analysis of alkaloids in the concoction of aconite roots with other 
Chinese medicine 
To some extent, the combinational principles of Fuzi can be explained by the chemical 
reactions in the concoction, namely, DDA will be changed to MDA and lipo-alkaloids in 
boiling water [1]. In addition, the acidity of solution has played an important role for these 
chemical reactions and high acidity will inhibit the hydrolysis of aconitines [4]. However, it is 
still not clear that whether the acidity is the only factor for the amounts of aconitines in 
concoction. In this study, we have selected 7 kinds of Chinese medicines of which decoction 
are acidic to answer this question. 
As shown in Table 1, the pH value of the Fuzi decoction is 4.73; the pH value of the 
decoction of Radix Glycyrrhizae is 5.54, the pH value of other 6 kinds of herbal medicine 
ranged from 3 to 4. The pH value of the concoction of aconite with others is similar with 
those of decoction.  
2.3 The MALDI-TOF analysis of alkaloids in prepared Fuzi and the decoction of Fuzi 
The MALDI-TOF spectrum of the ethanolic extract of prepared Fuzi provides a profile of the 
alkaloids. BHA, BMA and BAC are the main alkaloids in Prepared Fuzi, HA, DA, MA and 
10-OH-AC has been observed as the main aconitines (Fig.20). After decocting, the relative 
amounts of highly toxic aconitines have been reduced because they are heat-unstable [5,6]. 
2.4 The MALDI-TOF analysis of alksloids in the concoction of Fuzi with Radix 
Glycyrrhizae, Lonicera nitida and Rhizoma Chuanxiong 
It is well known that Radix Glycyrrhiza has the detoxify effect, so it is reasonable that almost 
no aconitines has been detected in the concoction of Fuzi with it except for low abundant 
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HA at m/z 616 (Fig.22). However, to our surprise, in the concoction of Fuzi with Lonicera 
nitida or Rhizoma Chuanxiong (Fig.23 and Fig.24), the relative intensity of aconitines is also 
low and other aconitines have been detected at noice lowel. Since the pH value of the 
concoction of Fuzi with Lonicera nitida and  Rhizoma Chuanxiong is respective 3.54 and 
3,75, these results have suggest that the acidity of concoction is not the only factor that effect 
the hydrolysis reactions of aconitines. 
 
Aconite roots 4.73 
Radix Glycyrrhizae (甘草) 5.54 
Lonicera nitida (金银花) 3.54 
Crateagus pinnatifida (山楂) 3.32 
Chaenomeles sinensis (木瓜) 3.95 
Rhizoma Chuanxiong (川穹) 3.75 
Herba Potulacae Oleraceae (马齿苋) 3.84 
Galla Chinensis (五倍子) 3.63 
Aconite roots+ Radix Glycyrrhizae (A+RG) 5.12 
Aconite roots+ Lonicera nitida    (A+LN) 3.22 
Aconite roots+ Crateagus pinnatifida (A+CP) 3.26 
Aconite roots+ Chaenomeles sinensis   (A+CS) 3.69 
Aconite roots+ Rhizoma Chuanxiong   (A+RC)  4.10 
Aconite roots+ Herba Potulacae Oleraceae (A+HPO) 3.87 
Aconite roots+ Galla Chinensis        (A+GC) 3.65 
Table 1. The pH value of the decoction of eight kinds of Chinese Medicine 
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Fig. 20. MALDI-TOF spectrum of the ethanol extract of prepared Fuzi  
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Fig. 21. MALDI-TOF spectrum of the decoction of prepared Fuzi  
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Fig. 22. MALDI-TOF spectrum of the concoction of prepared Fuzi with Radix Glycyrrhizae 
508.0 540.8 573.6 606.4 639.2 672.0
0
1.4E+
0
10
20
30
40
50
60
70
80
90
100
%
 I
n
te
n
s
it
y
Voyager Spec #1[B P = 590.2, 14272]
590.1759
591.1806
604.1817
616.1818575.1932
617.1855589.2033512.4264 556.1802 648.1489
 
Fig. 23. MALDI-TOF spectrum of the concoction of prepared Fuzi with Lonicera nitida  
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Fig. 24. MALDI-TOF spectrum of the concoction of prepared Fuzi with Rhizoma 
Chuanxiong  
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2.5 The MALDI-TOF analysis of alkaloids in the concoction of Fuzi with other 4 kinds 
of acidic herbal medicines 
As shown in Fig.25-Fig.28, when Fuzi was concocted with Crateagus pinnatifida, Galla 
Chinensis, Chaenomeles sinensis or Herba Potulacae Oleraceae respectively, the relative 
amounts of DDA were higher that those in decoction, which suggested that these four 
herbal medicines should not be concocted with Fuzi. However, owing to the point-to-point 
difference of MALDI source, a statistical analysis is necessary. All the results have been 
shown in Table 3-Table 11 and summarized in Table 12. 
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Fig. 25. MALDI-TOF spectrum of the concoction of prepared Fuzi with Crateagus 
pinnatifida  
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Fig. 26. MALDI-TOF spectrum of the concoction of prepared Fuzi with Galla Chinensis  
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Fig. 27. MALDI-TOF spectrum of the concoction of prepared Fuzi with Chaenomeles 
sinensis  
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Fig. 28. MALDI-TOF spectrum of the concoction of prepared Fuzi with Herba Potulacae 
Oleraceae  
 
 
 
 
Aconitum alkaloids Relative intensities Average 
value 
RSD 
1  2  3  4  5  6  7  
Benzoylhypaconine 
(m/z574) 
25.19 36.56 38.83 37.19 30.25 28.09 36.77 33.27  5.33  
Benzoylmesaconine 
(m/z590) 
100  100  100  100  100  100  100  100  0.00  
Benzoylaconine  
(m/z604) 
23.65 39.82 24.04 32.98 39.86 15.10 17.85 27.61  10.07  
Hypaconitine  
(m/z616) 
22.16 21.88 51.37 30.43 41.87 50.18 45.13 37.57  12.65  
Deoxyaconitine  
(m/z630) 
3.16  5.69  9.14  8.97  10.82 9.43  5.91 7.59  2.71  
Mesaconitine  
(m/z632) 
2.63  3.78  3.58  3.24  4.94  8.27  6.22 4.67  1.98  
Aconitine  
(m/z646) 
0.00  4.78  2.27  2.98  11.76 6.99  2.74 4.50  3.86  
10-OH-mesaconitine 
(m/z648) 
1.43  4.77  1.08  2.48  11.40 7.15  2.93 4.46  3.71  
10-OH-aconitine 
(m/z662) 
0.00  3.98  2.67  4.57  4.37  10.39 4.18 4.31  3.12  
 
 
 
Table 3. The average value of relative intestines of the detected peaks from prepared Fuzi for 
seven times 
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Aconitum alkaloids Relative intestines Average 
value 
RSD 
1  2  3  4  5  6  7  
Benzoylhypaconine 
(m/z574) 
65.08 54.99 52.73 56.36  61.57 60.03 74.30 60.72  7.31  
Benzoylmesaconine 
(m/z590) 
100  100  100  100  100  100  100  100  0.00  
Benzoylaconine  
(m/z604) 
28.22 29.91 25.67 21.63  25.71 28.18 23.78 26.16  2.86  
Hypaconitine  
(m/z616) 
38.76 31.93 22.43 22.25  30.74 38.88 22.85 29.69  7.39  
Deoxyaconitine  
(m/z630) 
4.12  5.00  3.00  11.71  4.14  3.98  6.82  5.54  2.97  
Mesaconitine 
(m/z632) 
2.44  3.20  4.06  6.51  2.26  2.80  6.68  3.99  1.87  
Aconitine 
 (m/z646) 
0.00  3.45  2.87  4.57  2.66  0.00  6.21  2.82  2.27  
10-OH-mesaconitine 
(m/z648) 
0.00  3.65  4.52  7.91  2.11  1.71  7.20  3.87  2.90  
10-OH-aconitine 
 (m/z662) 
0.00  0.00  5.87  3.41  0.00  2.85  7.43  2.79  3.02  
Table 4. The average value of relative intetie of the detected peaks from the detection of Fuzi 
for seven times 
 
Aconitum alkaloids 
Relative intestines Average 
value 
RSD 
1 2 3 4 5 6 7 
Benzoylhypaconine  
(m/z574) 
57.73 40.1640.63 51.59 55.97 53.19 52.16 50.20 7.04  
Benzoylmesaconine  
(m/z590) 
100 100 100 100 100 100 100 100 0  
Benzoylaconine  
(m/z604) 
23.91 24.0321.44 38.33 28.22 28.27 36.77 28.71 6.53  
Hypaconitine  
(m/z616) 
31.67 5.56 11.75 28.82 9.85 17.67 23.82 18.45 9.97  
Deoxyaconitine  
(m/z630) 
9.91 0 0 8.33 0 0 2.62 2.98 4.33  
Mesaconitine  
(m/z632) 
8.08 0 0 3.7 0 0 6.08 2.55 3.42  
Aconitine 
 (m/z646) 
5.51 1.91 2.13 2.21 0 0 4.13 2.27 2.02  
10-OH-mesaconitine 
(m/z648) 
6.71 0 1.63 2.21 0 0 5.65 2.31 2.80  
10-OH-aconitine  
(m/z662) 
4.4 0 2.2 2.5 0 0 10.13 2.75 3.66  
Table 5. The average value of relative intestines of the detected peaks from the concoction of 
Fuzi with Radix Glycyrrhiza for seven times 
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Aconitum alkaloids 
Relative intestines Average 
value 
RSD 
1  2  3  4  5  6  
Benzoylhypaconine (m/z574) 32.81 44.01 24.66 32.52 30.84 38.10 33.82  6.60  
Benzoylmesaconine (m/z590) 100  100  100  100  100  100  100  0.00  
Benzoylaconine (m/z604) 26.40 23.12 25.97 21.72 26.86 26.06 25.02  2.09  
Hypaconitine (m/z616) 15.43 11.11 12.24 23.16 12.01 13.42 14.56  4.47  
Deoxyaconitine (m/z630) 2.59  1.74  0.00  3.67  0.00  2.40  1.73  1.48  
Mesaconitine (m/z632) 0.00  4.72  2.68  3.75  0.00  2.90  2.34  1.95  
Aconitine (m/z646) 0.00  3.97  0.00  2.95  0.00  0.00  1.15  1.82  
10-OH-mesaconitine (m/z648) 2.33  9.11  0.00  3.49  0.00  2.71  2.94  3.35  
10-OH-aconitine (m/z662) 0.00  5.40  0.00  2.66  0.00  0.00  1.34  2.25  
Table 6. The average value of relative intestines of the detected peaks from the concocction 
of Fuzi with Lonicera nitida for six times 
 
Aconitum alkaloids Relative intestines Average 
value 
RSD 
1  2  3  
Benzoylhypaconine (m/z574) 37.02  17.91  21.42  25.45  10.17  
Benzoylmesaconine (m/z590) 100.00  100.00  100.00  100.00  0.00  
Benzoylaconine (m/z604) 22.79  21.14  15.60  19.84  3.77  
Hypaconitine (m/z616) 19.69  8.84  15.17  14.57  5.45  
Deoxyaconitine (m/z630) 0.00  0.00  0.00  0.00  0.00  
Mesaconitine (m/z632) 2.98  5.20  3.90  4.03  1.12  
Aconitine (m/z646) 0.00  0.00  0.00  0.00  0.00  
10-OH-mesaconitine (m/z648) 3.61  1.76  0.00  1.79  1.81  
10-OH-aconitine (m/z662) 0.00  0.00  1.76  0.59  1.02  
Table 7. The average value of relative intestines of the detected peaks from the concocction 
of Fuzi with Rhizoma Chuanxiong for three times 
www.intechopen.com
The MALDI-TOF Analysis of Aconitum Alkaloids 
in Proprietary Chinese Medicine and in the Concoction of Fuzi 
 
385 
Aconitum alkaloids Relative intestines Average   
value 
RSD 
1  2  3  4  5  6  
Benzoylhypaconine (m/z574) 35.39  38.94  21.33 40.68 40.24 28.24  34.14  7.79  
Benzoylmesaconine (m/z590) 100.00  100.0
0  
100.0
0  
100.0
0  
100.0
0  
100.00 100.00  0.00  
Benzoylaconine (m/z604) 22.79  18.42  21.20 22.46 21.01 24.09  21.66  1.95  
Hypaconitine (m/z616) 54.98  56.09  38.57 80.39 51.51 53.42  55.83  13.61  
Deoxyaconitine (m/z630) 9.86  5.56  8.57  7.49  13.16 12.54  9.53  2.94  
Mesaconitine (m/z632) 9.92  8.74  11.58 10.90 6.60  9.80  9.59  1.76  
Aconitine (m/z646) 3.86  3.56  2.42  4.54  3.85  4.56  3.80  0.79  
10-OH-mesaconitine (m/z648) 10.46  6.37  5.08  6.64  6.01  7.20  6.96  1.85  
10-OH-aconitine (m/z662) 3.71  4.33  0.00  3.62  4.71  3.06  3.24  1.69  
Table 8. The average value of relative intestines of the detected peaks from the concocction 
of Fuzi with Crateagus pinnatifida for six times 
 
Aconitum alkaloids 
Relative intestines Average 
value 
RSD 
1  2  3  4  5  6  7  
Benzoylhypaconine 
(m/z574) 
54.45  77.33 50.76 64.26 55.34 51.57 75.68 61.34  11.26  
Benzoylmesaconine 
(m/z590) 
89.18  98.06 84.35 84.77 100  100  81.59 91.14  8.03  
Benzoylaconine (m/z604) 41.47  36.27 25.70 59.23 38.73 44.37 39.13 40.70  10.07  
Hypaconitine (m/z616) 100  100  100  100  83.70 71.44 100 93.59  11.50  
Deoxyaconitine (m/z630) 11.65  13.77 12.18 27.91 13.89 7.47 11.48 14.05  6.47  
Mesaconitine (m/z632) 13.28  8.18  8.29  5.87  6.38 3.81 8.90 7.82  2.98  
Aconitine (m/z646) 3.11  4.25  9.76  10.47 3.46 0.00 8.90 5.71  4.00  
10-OH-mesaconitine 
(m/z648) 
3.96  4.78  10.82 13.53 6.57 6.87 10.06 8.08  3.48  
10-OH-aconitine (m/z662) 6.98  7.57  11.76 11.32 4.93 4.54 8.15 7.89  2.82  
Table 9. The average value of relative intestines of the detected peaks from the concocction 
of Fuzi with Galla Chinensis for seven times 
www.intechopen.com
 
Recent Advances in Theories and Practice of Chinese Medicine 
 
386 
Aconitum alkaloids Relative intestines Average 
value 
RSD 
1  2  3  4  5  6  7  
Benzoylhypaconine (m/z574) 41.22 33.60 25.68 29.67 48.78 44.39 33.30 36.66  8.34  
Benzoylmesaconine (m/z590) 1000 100  100  100  1000 100  100 100  0.00  
Benzoylaconine (m/z604) 37.32 23.85 39.65 27.92 27.20 18.33 33.73 29.71  7.60  
Hypaconitine (m/z616) 39.79 15.07 24.40 26.92 24.88 15.75 19.98 23.83  8.39  
Deoxyaconitine (m/z630) 7.76  2.94  9.67  6.85  4.92  6.86  8.78 6.83  2.29  
Mesaconitine (m/z632) 5.29  2.26  5.82  6.61  4.02  3.64  2.73 4.34  1.62  
Aconitine (m/z646) 6.28  2.90  7.55  9.68  4.84  3.85  2.00 5.30  2.71  
10-OH-mesaconitine (m/z648) 4.97  2.61  6.57  7.25  6.26  5.04  3.95 5.24  1.61  
10-OH-aconitine (m/z662) 3.59  2.84  5.97  8.17  5.83  2.78  4.09 4.75  1.99  
Table 10. The average value of relative intestines of the detected peaks from the concocction 
of Fuzi with Chaenomeles sinensis for seven times 
 
Aconitum alkaloids Relative intestines Average 
value 
RSD 
1 2 3 4 5   
Benzoylhypaconine 
(m/z574) 
30.49  51.63  20.61  43.12  30.06  35.18  12.19  
Benzoylmesaconine 
(m/z590) 
100  100  100  100  100  100  0.00  
Benzoylaconine (m/z604) 15.28  30.10  18.81  19.65  18.81  20.53  5.61  
Hypaconitine (m/z616) 33.70  57.20  34.36  92.86  46.45  52.91  24.34  
Deoxyaconitine (m/z630) 5.85  7.59  9.45  8.27  14.36  9.10  3.21  
Mesaconitine (m/z632) 5.56  5.71  4.61  7.46  10.20  6.71  2.21  
Aconitine (m/z646) 0.00  4.29  5.57  4.02  4.30  3.64  2.12  
10-OH-mesaconitine 
(m/z648) 
3.21  5.45  5.76  4.79  3.32  4.51  1.19  
10-OH-aconitine (m/z662) 2.95  4.55  6.10  5.93  4.16  4.74  1.31  
Table 11. The average value of relative intestines of the detected peaks from the concoction 
of Fuzi with Herbal Potulacae Oleraceae for five times 
www.intechopen.com
The MALDI-TOF Analysis of Aconitum Alkaloids 
in Proprietary Chinese Medicine and in the Concoction of Fuzi 
 
387 
 
Table 12. The average value of relative intestines of the detected peaks from the concocction 
and decoction of Fuzi  
Taken the ethanol extract of Fuzi as a standard, we will find that the DDAs have been 
reduced after decocting or concocting with Radix Glycyrrhizae, Lonicera nitida, Rhizoma 
Chuanxiong or Chaenomeles sinensis, respectively. Coincidentally, both Radix Glycyrrhizae 
and Lonicera nitida is the most popular medicine for detoxification. However, when Fuzi 
has been concocted with Crateagus pinnatifida, Galla Chinensis or Herba Potulacae 
Oleraceae, the relative amounts of all DDAs, especially of hypaconitine, have been increased 
significantly despite that the pH value of Lonicera nitida is smaller than that of Galla 
Chinensis and Herba Potulacae Oleraceae. The results have indicated that the detoxification 
mechanism of traditional Chinese medicine such as Fuzi is very complex and can not be 
explained by a simple reason such as pH value. In addition, our studies have suggested that 
although Crateagus pinnatifida, Galla Chinensis and Herba Potulacae Oleraceae is beyond 
the list that should not be combined with aconite according to traditional Chinese theory or 
experience, but they do increase the toxicity of Fuzi.  
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